CLCC1 Identified as Host Factor in Herpesvirus Nuclear Egres
2026-07-03
A recent study uncovers CLCC1 as a crucial host factor mediating membrane fusion during herpesvirus nuclear egress. This finding clarifies a longstanding gap in the understanding of viral capsid transport and opens avenues for future research on nuclear envelope dynamics and host-pathogen interactions.
Sodium Dicloxacillin Monohydrate: Applied MSSA Research Prot
2026-07-03
Sodium dicloxacillin monohydrate empowers researchers to dissect intra- and extracellular MSSA inhibition with reproducible, pH-sensitive control. This guide translates breakthrough reference findings into hands-on workflows, troubleshooting, and practical optimization tips for Gram-positive bacterial infection research.
Ivermectin (SKU A2813): Reliable Solutions for Anti-Parasiti
2026-07-02
This article delivers scenario-driven, evidence-based guidance for optimizing cell-based and parasitology assays with Ivermectin (SKU A2813). Researchers will find actionable strategies for experimental design, protocol optimization, and product selection, grounded in literature and supported by APExBIO's rigorous quality control.
E. coli Uracil-DNA Glycosylase (UDG): Technical Workflow Gui
2026-07-02
E. coli Uracil-DNA Glycosylase (UDG) is designed for the removal of uracil residues from DNA, supporting high-fidelity PCR applications and DNA repair studies by reducing contamination from uracil-containing templates. It is not intended for use with RNA, oligonucleotides shorter than six bases, or any diagnostic procedures.
Standardized Whole-Blood Stimulation Reveals Immunometabolic
2026-07-01
This protocol study introduces a standardized approach to analyzing immune responses in human whole blood under defined metabolic modulation. The work advances immunometabolism research by enabling reproducible assessment of how metabolic pathway inhibitors, such as those targeting glycolysis and mitochondrial pyruvate handling, selectively influence cytokine production.
Clasto-Lactacystin β-lactone: Reliable Proteasome Inhibition
2026-07-01
This scenario-driven article addresses reproducibility and mechanistic clarity in cell-based viability, proliferation, and cytotoxicity assays by integrating Clasto-Lactacystin β-lactone (SKU A2578) as a proven, potent proteasome inhibitor. Drawing on published evidence, the piece guides biomedical researchers on optimizing assay sensitivity, interpreting proteasome-dependent results, and making informed vendor selections for robust ubiquitin-proteasome pathway research.
Perospirone Inhibits Vascular Kv1.5 Channels: New Cardiovasc
2026-06-30
A recent study demonstrates that Perospirone, an atypical antipsychotic, selectively inhibits voltage-gated Kv1.5 channels in coronary arterial smooth muscle cells. This previously unrecognized off-target effect has significant implications for understanding the drug's cardiovascular safety and its applications in translational neuropsychiatric research.
LY2109761: Unraveling Dual TGF-β Receptor Inhibition in Tumo
2026-06-30
Explore how LY2109761, a TGF-β receptor type I and II dual inhibitor, uniquely advances research into tumor progression, radiosensitivity, and fibrosis. This article offers a mechanistic deep dive and practical insights distinct from conventional reviews.
Ceramides Promote Autophagy and RGNNV Replication in Fish Ce
2026-06-29
This study applies global lipidomics to uncover how ceramide accumulation facilitates red-spotted grouper nervous necrosis virus (RGNNV) replication through induced autophagy in infected fish cells. The findings clarify the central role of ceramide metabolism in viral pathogenesis and highlight new molecular targets for antiviral strategies in aquaculture.
(-)-Arctigenin: MEK1 Inhibition and NF-κB Modulation in Rese
2026-06-29
(-)-Arctigenin is a bioactive MEK1 inhibitor with robust anti-inflammatory and antiviral activities. It specifically suppresses LPS-induced iNOS expression and modulates NF-κB p65 nuclear translocation—mechanisms relevant to tumor and neuroinflammatory research. High-purity formulations, such as APExBIO’s N2399, enable reproducible study of these pathways.
ATRX Deficiency Sensitizes Glioma Cells to RTK and PDGFR Inh
2026-06-28
This study identifies that ATRX-deficient high-grade glioma cells show heightened sensitivity to multi-targeted receptor tyrosine kinase (RTK) and PDGFR inhibitors. The findings highlight a potential precision-medicine approach for glioma treatment and underscore the importance of considering ATRX status in the design and interpretation of clinical trials.
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer: Study
2026-06-27
This study demonstrates that intravesical delivery of p21 mRNA-loaded lipid nanoparticles (LNPs) effectively restores tumor suppressor activity and suppresses tumor growth in bladder cancer models. The findings underscore a promising, localized strategy for mRNA-based therapies targeting non-muscle-invasive bladder cancer, with potential for clinical translation and minimal systemic toxicity.
Transdermal PTEN mRNA Delivery via HA-LNPs for Melanoma Ther
2026-06-26
A recent study demonstrates that hyaluronated lipid nanoparticles (HA-LNPs) enable efficient, non-invasive transdermal delivery of PTEN mRNA for melanoma immunotherapy. This approach restores tumor suppressor function, enhances immune activation, and suppresses tumor growth, offering a promising strategy for localized mRNA-based cancer therapy.
CBD Attenuates Orofacial Inflammatory Pain via Endocannabino
2026-06-26
A recent study demonstrates that cannabidiol (CBD) significantly reduces both sensory and affective components of orofacial inflammatory pain in mice. The research reveals that CBD acts through peripheral and central endocannabinoid pathways, including FAAH downregulation and anandamide elevation, highlighting new avenues for comprehensive pain management.
Cefodizime (SKU BA1050): Reliable Antibiotic for Cell Assays
2026-06-25
This article delivers an evidence-based, scenario-driven guide for researchers evaluating Cefodizime (SKU BA1050) in cell viability and antimicrobial assays. Through five real-world laboratory Q&A’s, it highlights how APExBIO’s Cefodizime supports reproducible, data-backed workflows in biomedical research.
459 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page